上尿路尿路上皮癌（UTUC）是一种少见的恶性肿瘤，依据危险程度分为高危和低危两组。高危 UTUC 的标准治疗为 根治性肾输尿管切除术，目前主要在腹腔镜下进行。随着机器人辅助腹腔镜技术深入应用于泌尿外科领域，机器人辅助肾输 尿管切除术（RANU）的开展受到泌尿外科医师的广泛关注。本文聚焦于目前机器人辅助腹腔镜技术在高危 UTUC 的应用现状， 手术技术包括不同入路下患者体位及机械臂套管布置，膀胱袖状切除及重建，淋巴结清扫，以及术后的围手术期指标和肿瘤 学疗效等方面作一综述。

Upper tract urothelial carcinoma (UTUC) is a rare malignant tumor, which can be divided into the high-risk and low-risk groups according to the degree of risk. The standard treatment for high-risk UTUC is radical nephroureterectomy (RNU), which is currently performed primarily under laparoscope. With the in-depth application of robot-assisted laparoscopic technology in the field of urology, the development of robot-assisted RNU has received extensive attention from urologists. The current application status of robot-assisted laparoscopic technology in high-risk UTUC, including patient position and Trocar placement under different approaches, bladder sleeve resection and reconstruction, lymph node dissection, as well as postoperative perioperative indicators and oncological efficacy were reviewed in this paper.

基金项目：兰州大学医学教育创新发展项目（lzuyxcx-2022-106）；萃英科技创新计划项目（CY2021-MS-B16） 

Foundation Item: Medical Education Innovation and Development Project of Lanzhou University (lzuyxcx-2022-106); Cuiying Scientific  and Technological Innovation Plan Project (CY2021-MS-B16) 

引用格式：续万荣，尚攀峰，康子明 . 机器人辅助腹腔镜技术应用于高危上尿路尿路上皮癌治疗的研究进展 [J]. 机器人外科学杂志（中英文）， 2025，6（3）：508-513. 

Citation: XU W R, SHANG P F, KANG Z M, et al. Research progress of robot-assisted laparoscopic technology in the treatment of highrisk upper tract urothelial carcinoma[J]. Chinese Journal of Robotic Surgery, 2025,6(3): 508-513. 

通讯作者（Corresponding Author）：尚攀峰（SHANG Panfeng），E-mail：shangpf@lzu.edu.cn

[1] Petros F G. Epidemiology, clinical presentation, and evaluation of uppertract urothelial carcinoma[J]. Translational Andrology and Urology, 2020, 9(4): 1794-1798. 

[2] Rouprêt M, Seisen T, Birtle A J, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update[J]. European Urology, 2023, 84(1): 49-64. 

[3] 中国医师协会泌尿外科医师分会肿瘤专业委员会 , 中国医师协会泌 尿外科 , 医师分会上尿路尿路上皮癌 (CUDA-UTUC) 协作组 . 上尿路尿路上皮癌诊断与治疗中国专家共识 [J]. 中华泌尿外科杂志 , 2018, 39(7): 485-488. 

[4] Afferi L, Abufaraj M, Soria F, et al. A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis[J]. Minerva Urology and Nephrology, 2022, 74(1): 49-56. 

[5] 阮海龙 , 程功 , 陈志贤 , 等 . 机器人辅助单一体位经腹入路肾输尿管 切除 + 膀胱袖状切除术治疗 UTUC 的疗效 [J]. 中华泌尿外科杂志 , 2021, 42(11): 810-813. 

[6] XU C R, YUAN C W, ZHANG C J, et al. The evolution of clinicopathological diagnostic features of upper tract urothelial carcinoma in China: a summary of 2561 cases in the last 20 years[J]. Frontiers in Oncology, 2022, 12: 769252. 

[7] Herout R, Baunacke M, Flegar L, et al. Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019 [J]. World Journal of Urology, 2023, 41(1): 127-133. 

[8] Bae H, Chung J H, Song W, et al. Robotic radical nephroureterectomy with bladder cuff excision for upper tract urothelial carcinoma: a trend analysis of utilization and a comparative study[J]. Cancers, 2022, 14(10): 2497. 

[9] Veccia A, Antonelli A, Francavilla S, et al. Robotic versus other nephroureterectomy techniques: A systematic review and meta-analysis of over 87 000 cases[J]. World Journal of Urology, 2020, 38(4): 845-852. 

[10] Franco A, Ditonno F, Feng C, et al. Minimally invasive radical nephroureterectomy: 5-year update of techniques and outcomes[J]. Cancers, 2023, 15(18): 4585. 

[11] 丁国庆 , 王平 , 叶烈夫 , 等 . 机器人辅助腹腔镜治疗上尿路尿路上皮 癌专家共识 [J]. 微创泌尿外科杂志 , 2024, 13(2): 87-92. 

[12] de Groote R, Decaestecker K, Larcher A, et al. Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: results from three high-volume robotic surgery institutions[J]. Journal of Robotic Surgery, 2020, 14(1): 211-219. 

[13] YE H M, FENG X, WANG Y, et al. Single-docking robotic-assisted nephroureterectomy and extravesical bladder cuff excision without intraoperative repositioning: the technique and oncological outcomes[J]. Asian Journal of Surgery, 2020, 43(10): 978-985. 

[14] 苏子良 , 王越 , 贾光 , 等 . 机器人辅助腹腔镜改良“一体位”治疗上 尿路尿路上皮癌的短期疗效 [J]. 机器人外科学杂志 ( 中英文 ), 2022, 3(06): 477-481. 

[15] Sparwasser P, Epple S, Thomas A, et al. First completely robot-assisted retroperitoneal nephroureterectomy with bladder cuff: a step-by-step technique[J]. World Journal of Urology, 2022, 40(4): 1019-1026. 

[16] Hughes T, Rai B, Madaan S, et al. The availability, cost, limitations, learning curve and future of robotic systems in urology and prostate cancer surgery[J]. Journal of Clinical Medicine, 2023, 12(6): 2268. 

[17] Pellegrino A A, Chen G, Morgantini L, et al. Simplifying retroperitoneal robotic single-port surgery: novel supine anterior retroperitoneal access[J]. European Urology, 2023, 84(2): 223-228. 

[18] Bang S, Cho H J, Ha U S, et al. Retroperitoneal single-port robot-assisted nephroureterectomy with bladder cuff excision: initial experience and description of the technique[J]. Journal of Clinical Medicine, 2023, 12(18): 6091. 

[19] Stravodimos K G, Komninos C, Kural A R, et al. Distal ureterectomy techniques in laparoscopic and robot-assisted nephroureterectomy: updated review[J]. Urology Annals, 2015, 7(1): 8-16. 

[20] Pathak R A, Hemal A K. Techniques and outcomes of robot-assisted nephro-ureterectomy for upper tract urothelial carcinoma[J]. European Urology Focus, 2018, 4(5): 657-661. 

[21] WU Z J, LI M M, WANG J C, et al. Pure retroperitoneoscopic extravesical standardized seeable (PRESS) excision of distal ureter and bladder cuff in radical nephroureterectomy: step-by-step technique[J]. Minerva Urology and Nephrology, 2021, 73(3): 392-400. 

[22] Medina L G, Alsyouf M, Ghoreifi A, et al. Distal ureter and bladder cuff excision using the“Keyhole Technique”during Robotic Radical Nephroureterectomy[J]. Int Braz J Urol, 2022, 48(5): 876-877. 

[23] Yanagisawa T, Kawada T, Von Deimling M, et al. Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023[J]. Current Opinion in Urology, 2023, 33(4): 258-268. 

[24] LI C C, CHANG C H, HUANG C P, et al. Comparing oncological outcomes and surgical complications of hand-assisted, laparoscopic and robotic nephroureterectomy for upper tract urothelial carcinoma[J]. Frontiers in Oncology, 2021, 11: 731460. 

[25] Kenigsberg A P, Smith W, Meng X, et al. Robotic nephroureterectomy vs laparoscopic nephroureterectomy: increased utilization, rates of lymphadenectomy, decreased morbidity robotically[J]. Journal of Endourology, 2021, 35(3): 312-318. 

[26] Kanno T, Kobori G, Ito K, et al. Oncological outcomes of retroperitoneal lymph node dissection during retroperitoneal laparoscopic radical nephroureterectomy for renal pelvic or upper ureteral tumors: matched-pair analysis[J]. Journal of Endourology, 2022, 36(9): 1206-1213. 

[27] ZUO W, LI Z Y, QI T, et al. Robot-assisted radical nephroureterectomy using the KangDuo-surgical robot-01 system: a prospective, single-center, single-arm clinical study[J]. Journal of Endourology, 2024, 38(7): 661-667. 

[28] Grossmann N C, Soria F, Juvet T, et al. Comparing oncological and perioperative outcomes of open versus laparoscopic versus robotic radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: a multicenter, multinational, propensity score-matched analysis[J]. Cancers, 2023, 15(5): 1409. 

[29] Afferi L, Abufaraj M, Soria F, et al. A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis[J]. Minerva Urology and Nephrology, 2022, 74(1): 49-56. 

[30] LI K P, CHEN S Y, WANG C Y, et al. Comparison between robot-assisted versus open nephroureterectomy for upper tract urothelial carcinoma: outcomes from a pooled analysis[J]. Journal of Robotic Surgery, 2023, 17(4): 1227-1238. 

[31] Birtle A, Johnson M, Chester J, et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial[J]. Lancet, 2020, 395(10232): 1268-1277. 

[32] Muramoto K, Urabe F, Koike Y, et al. Perioperative renal function change and oncological outcomes of radical nephroureterectomy in patients with upper tract urothelial carcinoma: a multicenter retrospective study[J]. Urologic Oncology, 2024, 42(10): 332.e21-.e32. 

[33] Gabriel P E, Pinar U, Lenfant L, et al. Perioperative, renal function and oncological outcomes of robot-assisted radical nephroureterectomy for patients with upper tract urothelial carcinoma[J]. World Journal of Urology, 2023, 41(11): 3001-3007. 

[34] Martini A, Lonati C, Nocera L, et al. Oncologic surveillance after radical nephroureterectomy for high-risk upper tract urothelial carcinoma[J]. European Urology Oncology, 2022, 5(4): 451-459. 

[35] Pizzighella M, Bruyère F, Peyronnet B, et al. The management of distal ureter during radical nephroureterectomy does not influence bladder recurrence[J]. Journal of Endourology, 2022, 36(1): 77-82. 

[36] Zeuschner P, Vollmer S G, Linxweiler J, et al. Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: A retrospective cohort study across ten years [J]. Surgical oncology, 2021, 38: 101607.